Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

How Can We Prevent the Underdiagnosis of Diabetes and the Undertreatment of Known Diabetes in Patients With Inflammatory Arthritis Treated With Sulfasalazine?

NCT07416656 is registered in ClinicalTrials.gov with Klavs Würgler Hansen as lead sponsor.

NCT NCT07416656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07416656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
How Can We Prevent the Underdiagnosis of Diabetes and the Undertreatment of Known Diabetes in Patients With Inflammatory Arthritis Treated With Sulfasalazine?
Lead sponsor
Klavs Würgler Hansen
Phase
Observational
Overall status
Recruiting
Start date
March 10, 2026
Completion date
October 31, 2026
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes (dm), inflammatory arthritis, rheumatoid arthritis (ra), type 1 diabetes mellitus, type 2 diabetes (t2dm)